Study of SFA002 in Patients with Mild to Moderate Psoriasis Plaques

Recruiting

Phase 1

SFA002Study of SFA002 in Patients with Mild to Moderate Psoriasis Plaques

Sponsor:

SFA Therapeutics

Code:

NCT05642182

Conditions

Psoriasis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

SFA002

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-19. This information was provided to ClinicalTrials.gov by SFA Therapeutics on 2025-01-09.